文献速递银屑病与炎症性皮肤病

CDK7通过调控糖酵解促进银屑病Th17/Th1细胞分化

Cyclin-Dependent Kinase 7 Promotes Th17/Th1 Cell Differentiation in Psoriasis by Modulating Glycolytic Metabolism.
PubMed 文献 · J Invest Dermatol · 2021-05-15

该研究通过定量蛋白质组学发现银屑病患者CD4+ T细胞中CDK7表达显著升高且与疾病严重程度正相关。遗传或药物抑制CDK7可减轻咪喹莫特诱导的银屑病样小鼠模型严重程度,并抑制CD4+ T细胞活化及Th17/Th1分化。CDK7抑制剂还能降低患者CD4+ T细胞的增强糖酵解,机制涉及IL-23诱导的蛋白激酶B/mTOR/HIF-1α通路。

要点

  • 银屑病患者CD4+ T细胞CDK7表达升高,且与病情严重程度正相关
  • 抑制CDK7可减轻银屑病样小鼠模型严重程度并抑制Th17/Th1分化
  • CDK7通过蛋白激酶B/mTOR/HIF-1α通路调控糖酵解,靶向CDK7或为潜在免疫抑制策略

核心结论

  • CDK7通过调控糖酵解促进CD4+ T细胞活化及Th17/Th1细胞分化,参与银屑病发病机制。
  • 靶向CDK7可能是控制IL-23介导皮肤炎症的潜在免疫抑制策略。

研究设计与样本

  • 研究采用定量蛋白质组学分析银屑病患者与健康对照CD4+ T细胞的CDK7表达。
  • 利用咪喹莫特诱导的银屑病样小鼠模型及体外实验,采用遗传或药物抑制CDK7。

主要发现

  • 银屑病患者CD4+ T细胞CDK7表达较健康对照显著升高,且与银屑病严重程度正相关。
  • 遗传或药物抑制CDK7可改善咪喹莫特诱导小鼠银屑病样模型严重程度,并抑制CD4+ T细胞活化及Th17/Th1分化。
  • CDK7抑制剂可降低银屑病患者CD4+ T细胞增强的糖酵解。
  • IL-23诱导CD4+ T细胞CDK7表达升高并激活蛋白激酶B/mTOR/HIF-1α通路,增强糖酵解。
  • CDK7抑制通过蛋白激酶B/mTOR/HIF-1α通路显著削弱IL-23诱导的糖酵解。

临床怎么用

  • CDK7及其调控的糖酵解通路可作为银屑病免疫机制研究的潜在靶点。
  • CDK7抑制剂对IL-23介导的皮肤炎症可能具有潜在控制作用,尚需临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Excessive activation of CD4+ T cells and T helper type (Th) 17/Th1 cell differentiation are critical events in psoriasis pathogenesis, but the associated molecular mechanism is still unclear. Here, using quantitative proteomics analysis, we found that cyclin-dependent kinase 7 (CDK7) expression was markedly increased in CD4+ T cells from patients with psoriasis compared with healthy controls and was positively correlated with psoriasis severity. Meanwhile, genetic or pharmacological inhibition of CDK7 ameliorated the severity of psoriasis in the imiquimod-induced psoriasis-like mouse model and suppressed CD4+ T-cell activation as well as Th17/Th1 cell differentiation in vivo and in vitro. Furthermore, the CDK7 inhibitor also reduced the enhanced glycolysis of CD4+ T cells from patients with psoriasis. Proinflammatory cytokine IL-23 induced increased CDK7 expression in CD4+ T cells and activated the protein kinase B/mTOR/HIF-1α signaling pathway, enhancing glycolytic metabolism. Correspondingly, CDK7 inhibition significantly impaired IL-23-induced glycolysis via the protein kinase B/mTOR/HIF-1α pathway. In summary, this study shows that CDK7 promotes CD4+ T-cell activation and Th17/Th1 cell differentiation by regulating glycolysis, thus contributing to the pathogenesis of psoriasis. Targeting CDK7 might be a promising immunosuppressive strategy to control skin inflammation mediated by IL-23.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Lin Y, Xue K, Li Q, et al. Cyclin-Dependent Kinase 7 Promotes Th17/Th1 Cell Differentiation in Psoriasis by Modulating Glycolytic Metabolism. J Invest Dermatol. 2021. PMID: 34004188. doi:10.1016/j.jid.2021.04.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。